A3685 - Survival with Optimal Medical Management in a Cohort of Severe Necrotizing Bacterial Lung Infection
Presenter:
Date
05/20/2019
Room
Area H (Hall F, Level 2), KBHCCD
Session Name
B57 - CLINICAL STUDIES IN LUNG INFECTIONS: RISK FACTORS AND BIOMARKERS
Authors
A3038 - Characterizing a Digital Health Footprint for Asthma
Presenter:
Date
05/20/2019
Room
Area E (Hall F, Level 2), KBHCCD
Session Name
B37 - NOVEL APPROACHES TO ASTHMA MANAGEMENT AND OUTCOMES
Authors
A2436 - Influence of Age on the Efficacy of Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
Presenter:
Date
05/19/2019
Room
Room C141/C143/C149 (Level 1), KBHCCD
Session Name
A102 - COPD: THERAPY
A6730 - An Audit of Paediatric Asthma Management in a Developing Country
Presenter:
Date
05/22/2019
Room
Area H (Hall F, Level 2), KBHCCD
Session Name
D53 - PEDIATRIC ASTHMA CLINICAL STUDIES
Authors
A2788 - The Effects of Chronic Illness on Mental Health and Sleep: A Comparison of Pediatric Cystic Fibrosis and Asthma
Presenter:
Date
05/20/2019
Room
Trinity Ballroom 1-3 (Level 3), Omni Dallas Downtown
Session Name
B26 - CLINICAL STUDIES IN PEDIATRIC SLEEP, HOME VENTILATION AND NEUROMUSCULAR DISEASE
A5958 - Disease Severity of Patients with High Blood Eosinophil Counts Treated for COPD Exacerbation with or Without Oral Corticosteroids
Presenter:
Date
05/22/2019
Room
Room C141/C143/C149 (Level 1), KBHCCD
Session Name
D23 - COPD: DIAGNOSIS AND EPIDEMIOLOGY
A1548 - Pulmonary Sarcoidosis and Pilomatricoma
Presenter:
Date
05/19/2019
Room
Area D (Hall F, Level 2), KBHCCD
Session Name
A40 - INFLAMMATORY DPLDs CASE REPORTS
Authors
A5706 - Pseudomonas Aeruginosa Is Associated with Greater Frequency of Exacerbations Among Patients with Non-Cystic Fibrosis Bronchiectasis in the United States
Presenter:
Date
05/21/2019
Room
Ballroom A Four (Level 2), KBHCCD
Session Name
C105 - BRONCHIECTASIS: FROM CLINICAL PHENOTYPES TO TREATMENT
A1021 - Heat Shock Protein (HSP) 90 Inhibitors Prevent the Development of Nitrogen Mustard-Induced Chronic Lung Injury and Pulmonary Fibrosis in Mice
Presenter:
Date
05/19/2019
Room
Dallas Ballroom G (Level 3), Omni Dallas Downtown
Session Name
A16 - CHEMICAL THREATS AND INJURY: MECHANISMS AND TREATMENT
A3153 - Custom Stent Planning for Complex Airway Disease: A Novel "State-of-the-Art" Approach
Presenter:
Date
05/20/2019
Room
Area C (Hall F, Level 2), KBHCCD
Session Name
B41 - INTERVENTIONAL PULMONOLOGY CASE REPORTS I
A7152 - Epidemiology and Outcomes of Cancer-Related and Non-Cancer-Related U.S. Sepsis Hospitalizations
Presenter:
Date
05/22/2019
Room
Trinity Ballroom 5-7 (Level 3), Omni Dallas Downtown
Session Name
D104 - CRITICAL CARE: A FINE BALANCE - SEPSIS DEFINITIONS, OUTCOMES AND EPIDEMIOLOGY
Authors
A2667 - Dupilumab Reduces Severe Exacerbations and Improves Lung Function in Late-Onset, Uncontrolled, Moderate-to-Severe Asthma Patients Enrolled in the LIBERTY ASTHMA QUEST Study
Presenter:
Date
05/20/2019
Room
Room D222-D224 (Level 2), KBHCCD
Session Name
B21 - SEVERE ASTHMA: CLINICAL AND MECHANISTIC STUDIES